| Literature DB >> 32551232 |
Renata Sisto1, Pasquale Capone1, Luigi Cerini1, Enrico Paci1, Daniela Pigini1, Monica Gherardi1, Andrea Gordiani1, Nunziata L'Episcopo1, Giovanna Tranfo1, Pieranna Chiarella1.
Abstract
In the framework of a project aimed at finding novel predictive biomarkers of VOCs exposure-related diseases, the effect of exposure to ethylbenzene, toluene, and xylene has been analyzed in a group of painters (spray- and roller-painters) working in the shipyard industry. Airborne levels of solvents were higher in spray- than in roller-painters, and comparable to the Occupational Exposure Limits (OELs), particularly for toluene and xylene. The urinary concentration of each volatile organic compound (VOC) and of the corresponding metabolites were also concurrently measured. A set of oxidative stress biomarkers, i.e., the products of DNA and RNA oxidation, RNA methylation, and protein nitration, were measured, and found significantly higher at the end of the work shift. MicroRNA (MiRNA) expression was analyzed in the VOC-exposed workers and in a control group, finding 56 differentially expressed (DE) miRNAs at a statistically significant level (adjusted p ≤ 0.01). The Receiver-Operating Characteristic curves, computed for each identified miRNA, showed high sensitivity and specificity. A pathway analysis in the Kyoto Encyclopedia of Genes and Genomes (KEGG) showed that miRNA-1, which was found downregulated in exposed workers, is involved in the lung cancer oncogenesis. A subset of 10 miRNAs (out of the 56 DE) was selected, including those with the highest correlation to the urinary dose biomarkers measured at the end of work-shift. Multivariate ANOVA analysis showed a statistically significant correlation between the urinary dose biomarkers (both the VOCs urinary concentration and the VOCs' metabolite concentration), and the identified miRNA subset, indicating that the exposure to low VOC doses may be sufficient to activate the miRNA response. Four miRNAs belonging to the subset strongly related to the VOCs and VOCs' metabolites concentration were individuated, miR-589-5p, miR-941, miR-146b-3p and miR-27a-3p, with well-known implications in oxidative stress and inflammation processes.Entities:
Keywords: Biological monitoring; DE, differently expressed; KEGG, Kyoto Encyclopedia of Genes and Genomes; MHIPPA, methylhippuric acid; OELs, Occupational Exposure Limits; Painting; SBMA, S-Benzylmercapturic acid; SPMA, S- Phenylmercapturic acid; Urinary biomarkers; VOCs; VOCs, volatile organic compounds; VOCs’ metabolites; miRNA, MicroRNA; microRNA
Year: 2020 PMID: 32551232 PMCID: PMC7287141 DOI: 10.1016/j.toxrep.2020.05.006
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Analytic description of workers and controls. The results of the statistical tests for comparison between roller and spray painters are also shown.
| ID | Nationality | Sex | Age | Job task | Smoking habit |
|---|---|---|---|---|---|
| 1C | Italy | Male | 40 | Research | no |
| 2C | Italy | Male | 37 | Research | no |
| 3C | Italy | Male | 48 | Research | no |
| 1E | Bangladesh | Male | 21 | roller-painting | no |
| 2E | Bangladesh | Male | 35 | roller-painting | yes |
| 3E | Bangladesh | Male | 39 | roller-painting | no |
| 4E | Bangladesh | Male | 43 | spray-painting | yes |
| 5E | Bangladesh | Male | 48 | roller-painting | no |
| 6E | Bangladesh | Male | 40 | spray-painting | no |
| 7E | Bangladesh | Male | 42 | roller-painting | no |
| 8E | Bangladesh | Male | 38 | spray-painting | no |
| 9E | Bangladesh | Male | 44 | spray-painting | yes |
| 10E | Bangladesh | Male | 36 | roller-painting | no |
| 11E | Bangladesh | Male | 43 | roller-painting | no |
| 12E | Iraq | Male | 40 | roller-painting | yes |
| 13E | Bangladesh | Male | 26 | roller-painting | no |
| 15E | Bangladesh | Male | 32 | roller-painting | N/A |
| 16E | Bangladesh | Male | 34 | roller-painting | no |
| 17E | Bangladesh | Male | 54 | spray-painting | yes |
| 18E | Tunisia | Male | 49 | spray-painting | no |
| roller –spray comparison test | Pearson χ square | Students’ | Pearson |
Analytical methods and Limits of Detection for urinary metabolites.
| Risk Agent | Biomarker | Limit of Detection (LoD) |
|---|---|---|
| Ethylbenzene | Phenylglyoxylic acid | 0.015 mg/L |
| Ethylbenzene | Mandelic acid | 0.02 mg/L |
| Xylenes | Methylhyppuric acid | 1 μg/mL |
| Toluene | S-Benzylmercapturic acid | 0.35 μg/L |
| Benzene | S-Phenylmercapturic acid | 0.026 μg/L |
| Nicotine (active smoking) | Cotinine | 12.41 μg/L |
| Oxidative stress on DNA | 8-oxo-7,8-dihydro-2′-deoxyguanosine | 0.5 μg/L |
| Oxidative stress on RNA | 8-oxo-7,8-dihydroguanosine | 0.7 μg/L |
| Oxidative stress on DNA and RNA | 8-oxo-7,8-dihydroguanine | 0.5 μg/L |
| Nitrosative stress on proteins | 3-nitrotyrosine | 1.0 μg/L |
| Methylation of RNA | 5-methylcytidine | 0.01 μg/L |
airborne concentration of the most important VOCs present in the mixture for the roller- and spray-painting activities. The ratio between the airborne concentration and the relative Occupational Exposure Limit (OEL) is also reported. The result of the t-test used for comparison between roller and spray painters is also shown.
| toluene | ethylbenzene | p-xylene | m-xylene | o-xylene | xylenes | |
|---|---|---|---|---|---|---|
| mg/m3 | ||||||
| mean | 0.54 | 3.60 | 3.62 | 9.07 | 2.52 | 15.21 |
| OEL ratio | 0.00 | 0.01 | 0.01 | 0.04 | 0.01 | 0.06 |
| median | 0.17 | 1.00 | 0.69 | 2.14 | 0.41 | 3.17 |
| SD | 0.76 | 5.58 | 6.72 | 15.89 | 5.68 | 28.23 |
| 5th | 0.02 | 0.10 | 0.08 | 0.23 | 0.07 | 0.43 |
| 25th | 0.05 | 0.34 | 0.30 | 0.75 | 0.19 | 1.27 |
| 75th | 0.68 | 4.79 | 3.46 | 9.45 | 1.16 | 14.07 |
| 95th | 1.81 | 12.44 | 14.24 | 34.39 | 11.21 | 59.84 |
| max | 2.05 | 16.49 | 19.84 | 47.07 | 16.54 | 83.44 |
| min | 0.02 | 0.04 | 0.04 | 0.10 | 0.03 | 0.17 |
| mean | 78.81 | 25.25 | 26.22 | 64.92 | 22.82 | 113.96 |
| OEL ratio | 0.41 | 0.06 | 0.12 | 0.29 | 0.10 | 0.52 |
| median | 0.82 | 23.45 | 24.24 | 59.12 | 19.96 | 109.36 |
| SD | 121.51 | 17.15 | 21.35 | 48.37 | 19.95 | 88.43 |
| 5th | 0.13 | 6.41 | 4.77 | 13.21 | 4.25 | 22.23 |
| 25th | 0.23 | 13.67 | 9.01 | 29.83 | 5.51 | 44.37 |
| 75th | 169.00 | 37.59 | 43.19 | 103.57 | 39.48 | 184.18 |
| 95th | 240.73 | 45.67 | 50.11 | 121.02 | 45.17 | 210.61 |
| max | 246.02 | 47.83 | 51.99 | 124.98 | 46.50 | 218.15 |
| min | 0.1 | 4.04 | 3.38 | 7.83 | 3.83 | 15.04 |
| 0.044 | 0.003 | 0.007 | 0.005 | 0.009 | 0.006 |
Urinary concentration of the solvents present in the mixture at the beginning and at the end of the work-shift in the groups of roller- and spray-painters. The p value of the Students’ t-test for the comparison between roller and spray painters at the end of the woks-shift is also shown.
| ethylacetate | benzene | toluene | ethylbenzene | p-xylene | m-xylene | o-xylene | Total | |
|---|---|---|---|---|---|---|---|---|
| ng/mL | ||||||||
| roller | ||||||||
| Mean | na | 4.9 | na | 6.2 | 2.7 | 12.1 | na | 6.8 |
| Median | na | 3.6 | na | 7.5 | 2.3 | 13.9 | na | 3.3 |
| SD | na | 4.3 | na | 2.6 | 1.2 | 6.4 | na | 7.6 |
| 5th | na | 1.6 | na | 2.7 | 1.1 | 5.8 | na | 1.5 |
| 25th | na | 1.7 | na | 3.4 | 2.1 | 9.4 | na | 2.1 |
| 75th | na | 6.8 | na | 7.7 | 3.7 | 15.6 | na | 6.8 |
| 95th | na | 9.9 | na | 9.0 | 4.3 | 17.0 | na | 20.2 |
| max | na | 10.7 | na | 9.3 | 4.4 | 17.4 | na | 21.5 |
| min | na | 1.5 | na | 2.5 | 1.0 | 4.9 | na | 1.2 |
| Mean | 76.1 | 25.9 | 7.6 | 8.3 | 5.3 | 43.1 | 46.6 | 52.7 |
| Median | 76.1 | 2.2 | 7.6 | 5.5 | 2.6 | 15.5 | 46.6 | 19.3 |
| SD | 56.1 | 59.5 | 0.3 | 9.5 | 8.0 | 49.5 | 20.7 | 77.0 |
| 5th | 40.4 | 1.6 | 7.3 | 3.4 | 1.5 | 13.9 | 33.4 | 6.8 |
| 25th | 56.3 | 1.9 | 7.4 | 4.0 | 2.0 | 14.6 | 39.3 | 18.1 |
| 75th | 95.9 | 7.8 | 7.7 | 7.3 | 3.9 | 57.9 | 53.9 | 33.1 |
| 95th | 111.8 | 119.7 | 7.8 | 22.8 | 17.3 | 91.8 | 59.7 | 158.0 |
| max | 115.8 | 172.0 | 7.8 | 34.9 | 27.8 | 100.2 | 61.2 | 189.2 |
| min | 36.4 | 1.5 | 7.2 | 3.3 | 1.2 | 13.7 | 32.0 | 3.9 |
| Mean | na | 4.4 | na | 4.4 | 2.4 | na | na | 9.6 |
| Median | na | 3.8 | na | 3.4 | 1.7 | na | na | 1.7 |
| SD | na | 2.0 | na | 3.3 | 2.1 | na | na | 19.5 |
| 5th | na | 2.8 | na | 2.2 | 1.1 | na | na | 1.1 |
| 25th | na | 2.9 | na | 2.8 | 1.3 | na | na | 1.3 |
| 75th | na | 5.2 | na | 3.8 | 2.1 | na | na | 2.1 |
| 95th | na | 6.8 | na | 9.2 | 5.6 | na | na | 37.6 |
| max | na | 7.1 | na | 11.0 | 6.7 | na | na | 49.4 |
| min | na | 2.7 | na | 2.0 | 1.0 | na | na | 1.0 |
| Mean | 447.7 | 21.9 | 186.6 | 29.2 | 27.7 | 86.7 | 52.3 | 149.3 |
| Median | 312.9 | 11.1 | 159.9 | 16.3 | 15.3 | 50.0 | 33.3 | 90.7 |
| SD | 531.0 | 26.9 | 182.1 | 27.9 | 34.1 | 86.0 | 44.9 | 163.5 |
| 5th | 28.9 | 4.4 | 10.9 | 14.4 | 7.4 | 34.0 | 24.2 | 41.9 |
| 25th | 30.0 | 4.8 | 21.0 | 14.7 | 9.0 | 38.3 | 26.3 | 52.5 |
| 75th | 730.5 | 28.2 | 326.8 | 25.8 | 23.1 | 84.8 | 59.4 | 144.3 |
| 95th | 1055.3 | 54.7 | 398.8 | 70.9 | 78.1 | 215.6 | 106.9 | 392.8 |
| max | 1136.5 | 61.3 | 416.8 | 85.0 | 96.1 | 256.4 | 118.8 | 471.2 |
| min | 28.6 | 4.2 | 8.4 | 14.4 | 7.2 | 32.9 | 23.7 | 41.0 |
| 0.042 | n.s. | 0.043 | 0.023 | 0.018 | 0.029 | 0.05 | 0.031 |
na means that the value is below the detection limit.
concentrations at the beginning and at the end of the work-shift of the different urinary solvent metabolites present in the mixture in the groups of roller- and spray-painters. The 2nd and 4th peak of the MHIPP acid are both reported as MHIPP2 and MHIPP4 respectively. The p value of the comparison between roller and spray painters at the end of the work-shift is also reported.
| MA | PGA | SPMA | 2 MHIPP | 4 MHIPP | SBMA | Cotinine | ||
|---|---|---|---|---|---|---|---|---|
| roller | Mean | 9031.8 | 24537.3 | 0.39 | 1470.3 | 7274.7 | 4.5 | 234.9 |
| Median | 530.0 | 660.0 | 0.03 | 455.0 | 2558.8 | 3.1 | 16.8 | |
| SD | 26766.6 | 78229.5 | 0.79 | 2318.6 | 11909.0 | 3.2 | 331.2 | |
| 5th perc | 320.0 | 340.0 | 0.01 | 149.9 | 1287.7 | 1.8 | 3.5 | |
| 25th perc | 360.0 | 520.0 | 0.02 | 308.5 | 1637.7 | 2.6 | 6.0 | |
| 75th perc | 1490.0 | 1540.0 | 0.15 | 1141.7 | 6613.9 | 4.9 | 457.0 | |
| 95th perc | 46670.0 | 131395.0 | 1.94 | 5678.0 | 26840.1 | 10.4 | 790.5 | |
| max | 89680.0 | 260400.0 | 2.34 | 7824.6 | 41660.0 | 12.6 | 877.7 | |
| min | 310.0 | 310.0 | 0.01 | 114.3 | 1167.9 | 1.4 | 3.4 | |
| Mean | 6690.9 | 4342.7 | 1.23 | 9647.5 | 39859.0 | 14.1 | 638.4 | |
| Median | 3600.0 | 2250.0 | 0.33 | 4217.8 | 26151.6 | 15.9 | 25.5 | |
| SD | 8589.5 | 3939.5 | 2.36 | 16188.1 | 36540.5 | 5.7 | 969.1 | |
| 5th perc | 1450.0 | 1410.0 | 0.00 | 1436.3 | 11230.6 | 5.9 | 8.5 | |
| 25th perc | 1655.0 | 1675.0 | 0.04 | 2215.1 | 13136.0 | 9.9 | 16.4 | |
| 75th perc | 6940.0 | 6145.0 | 0.49 | 9020.5 | 50926.9 | 17.0 | 1175.5 | |
| 95th perc | 21490.0 | 11230.0 | 5.75 | 33850.7 | 101510.3 | 21.9 | 2263.2 | |
| max | 30390.0 | 13320.0 | 7.39 | 57472.0 | 129540.6 | 22.0 | 2592.5 | |
| min | 1290.0 | 1250.0 | 0.00 | 1399.6 | 9973.3 | 5.8 | 8.1 | |
| Mean | 1130.0 | 1076.7 | 1.83 | 1287.1 | 4741.8 | 7.3 | 1418.0 | |
| Median | 810.0 | 1210.0 | 0.42 | 1311.6 | 4800.8 | 7.2 | 412.6 | |
| SD | 963.2 | 595.1 | 2.83 | 547.4 | 2507.5 | 4.5 | 2229.1 | |
| 5th perc | 332.5 | 370.0 | 0.03 | 668.7 | 1991.6 | 2.3 | 3.2 | |
| 25th perc | 472.5 | 555.0 | 0.06 | 851.4 | 2550.2 | 3.5 | 4.5 | |
| 75th perc | 1425.0 | 1520.0 | 2.38 | 1718.0 | 6819.9 | 10.6 | 1702.7 | |
| 95th perc | 2542.5 | 1680.0 | 6.08 | 1880.1 | 7498.7 | 12.6 | 4758.2 | |
| max | 2850.0 | 1730.0 | 7.13 | 1924.8 | 7643.1 | 12.9 | 5678.7 | |
| min | 320.0 | 350.0 | 0.02 | 623.2 | 1913.0 | 2.2 | 2.8 | |
| Mean | 8503.3 | 4495.0 | 2.65 | 17233.5 | 89310.8 | 15.9 | 2132.0 | |
| Median | 5420.0 | 4985.0 | 1.11 | 19421.7 | 81611.6 | 12.7 | 583.4 | |
| SD | 7928.5 | 2268.5 | 3.56 | 11200.1 | 36247.4 | 8.5 | 3819.2 | |
| 5th perc | 1732.5 | 1615.0 | 0.27 | 3960.1 | 55822.3 | 8.1 | 7.8 | |
| 25th perc | 3982.5 | 2832.5 | 0.86 | 7562.2 | 68674.5 | 10.8 | 12.3 | |
| 75th perc | 11140.0 | 5877.5 | 2.69 | 27055.3 | 95805.3 | 19.9 | 1662.9 | |
| 95th perc | 20127.5 | 6990.0 | 8.00 | 27853.5 | 141209.6 | 28.0 | 7788.7 | |
| max | 22560.0 | 7280.0 | 9.60 | 27917.9 | 155537.3 | 30.2 | 9773.5 | |
| min | 1070.0 | 1430.0 | 0.10 | 3430.7 | 52205.5 | 7.2 | 7.0 | |
| n.s | n.s | n.s | n.s. | 0.009 | n.s | n.s. | ||
Concentrations at the beginning and at the end of the work- shift of the DNA and RNA oxidation products, 8-oxoGuo, 8-oxodGuo and 8-oxoGua, 3NO2tyrosine and 5-methylcytidine in the roller- and spray-painters. The result of the t-test, relative to the comparison between roller and spray painters, is also reported.
| 8-oxoGua | 8-oxoGuo | 8-oxodGuo | 3NO2tyrosine | 5-methylcytidine | ||
|---|---|---|---|---|---|---|
| Work-shift beginning | μg/g Creatinine | |||||
| roller | Mean | 7.70 | 8.85 | 2.80 | 3.55 | 4.40 |
| Median | 6.31 | 7.00 | 2.78 | 1.11 | 3.27 | |
| SD | 7.52 | 5.00 | 0.90 | 6.79 | 3.70 | |
| 5th perc | 0.22 | 5.30 | 1.61 | 0.52 | 1.52 | |
| 25th perc | 2.31 | 5.57 | 2.25 | 0.80 | 1.85 | |
| 75th perc | 9.27 | 8.82 | 3.09 | 2.53 | 5.15 | |
| 95th perc | 21.29 | 18.59 | 4.29 | 14.00 | 10.55 | |
| max | 21.99 | 18.69 | 4.42 | 23.68 | 14.20 | |
| min | 0.03 | 5.11 | 1.52 | 0.47 | 1.37 | |
| Work-shift end | ||||||
| roller | Mean | 9.97 | 14.51 | 5.23 | 3.55 | 7.92 |
| Median | 5.76 | 14.72 | 5.59 | 3.47 | 6.89 | |
| SD | 12.26 | 4.10 | 1.57 | 1.82 | 3.56 | |
| 5th perc | 0.01 | 10.00 | 3.38 | 1.46 | 4.22 | |
| 25th perc | 0.45 | 10.91 | 3.92 | 2.42 | 5.17 | |
| 75th perc | 18.85 | 17.61 | 6.24 | 4.32 | 10.19 | |
| 95th perc | 28.92 | 20.22 | 7.50 | 6.13 | 13.39 | |
| max | 29.00 | 21.77 | 7.53 | 7.80 | 13.53 | |
| min | 0.01 | 9.94 | 2.99 | 1.06 | 3.58 | |
| spray | Mean | 25.09 | 12.86 | 2.97 | 3.23 | 7.81 |
| Median | 18.97 | 9.51 | 2.74 | 1.75 | 5.37 | |
| SD | 20.29 | 9.42 | 0.95 | 3.20 | 7.56 | |
| 5th perc | 10.77 | 4.88 | 2.06 | 0.70 | 1.95 | |
| 25th perc | 12.02 | 6.10 | 2.18 | 0.82 | 3.05 | |
| 75th perc | 25.64 | 17.12 | 3.76 | 5.45 | 8.83 | |
| 95th perc | 54.89 | 26.43 | 4.16 | 7.63 | 19.00 | |
| max | 64.37 | 28.83 | 4.21 | 8.01 | 22.10 | |
| min | 10.66 | 4.71 | 2.05 | 0.70 | 1.74 | |
| Work-shift end | ||||||
| spray | Mean | 13.47 | 19.10 | 6.09 | 4.05 | 10.71 |
| Median | 8.09 | 15.80 | 5.72 | 2.75 | 5.96 | |
| SD | 17.01 | 8.35 | 2.46 | 3.44 | 11.26 | |
| 5th perc | 0.90 | 11.37 | 3.78 | 1.64 | 4.75 | |
| 25th perc | 4.04 | 13.68 | 5.20 | 1.93 | 5.73 | |
| 75th perc | 13.35 | 25.13 | 5.96 | 4.35 | 8.07 | |
| 95th perc | 38.68 | 30.27 | 9.53 | 9.20 | 27.31 | |
| max | 46.63 | 31.16 | 10.71 | 10.65 | 33.51 | |
| min | 0.22 | 10.62 | 3.35 | 1.62 | 4.42 | |
| n.s. | n.s. | n.s. | n.s. | n.s. |
List of miRNA differentially expressed (p-value ≤ 0.01) in exposed and control subjects. The area under the ROC curve and the sensitivity and specificity of each miRNA in discriminating exposed from control subjects is also reported.
| Na | Regulation | Log2 fold change | p -value | ROC curve: area under the curve | Sensitivity; |
|---|---|---|---|---|---|
| hsa-miR-1 | downregulated | −8.34 | 9.52E-28 | 0.98 | 94.1%; 100 % |
| hsa-miR-483−3p | downregulated | −4.77 | 5.78E-10 | 1 | 100 %; 100 % |
| hsa-miR-1249 | downregulated | −4.33 | 8.77E-09 | 1 | 100 %; 100 % |
| hsa-miR-4646−3p | downregulated | −4.38 | 2.52E-08 | 1 | 100 %; 100 % |
| hsa-miR-215−5p | downregulated | −2.63 | 9.43E-08 | 1 | 100 %; 100 % |
| hsa-miR-885−3p | downregulated | −3.72 | 1.09E-06 | 0.86 | 100 %; 86.7 % |
| hsa-miR-34a-5p | downregulated | −1.99 | 5.63E-06 | 1 | 100 %; 100 % |
| hsa-miR-497−5p | downregulated | −2.64 | 7.56E-06 | 1 | 100 %; 100 % |
| hsa-miR-122−5p | downregulated | −3.14 | 1.16E-05 | 0.96 | 88.2%; 100 % |
| hsa-miR-195−5p | downregulated | −1.82 | 3.19E-05 | 1 | 100 %; 100 % |
| hsa-miR-206 | downregulated | −3.01 | 3.28E-05 | 1 | 100 %; 100 % |
| hsa-miR-3613−5p | downregulated | −1.92 | 5.04E-05 | 0.98 | 94.1%;100 % |
| hsa-miR-203a | downregulated | −2.87 | 7.36E-05 | 0.98 | 94.1%;100 % |
| hsa-miR-375 | downregulated | −2.72 | 8.34E-05 | 1 | 100 %; 100 % |
| hsa-miR-141−3p | downregulated | −2.04 | 1.08E-04 | 1 | 100 %; 100 % |
| hsa-miR-92b-3p | downregulated | −1.96 | 1.39E-04 | 1 | 100 %; 100 % |
| hsa-miR-218−5p | downregulated | −2.64 | 2.01E-04 | 0.80 | 100 % ; 66.7 % |
| hsa-miR-200a-3p | downregulated | −1.95 | 2.76E-04 | 1 | 100 %; 100 % |
| hsa-miR-486−3p | downregulated | −1.71 | 6.46E-04 | 1 | 100 %; 100 % |
| hsa-miR-6803−3p | downregulated | −2.41 | 8.72E-04 | 1 | 100 %; 100 % |
| hsa-miR-429 | downregulated | −2.06 | 1.69E-03 | 1 | 100 %; 100 % |
| hsa-miR-486−5p | downregulated | −1.39 | 2.24E-03 | 0.98 | 94.1%; 100 % |
| hsa-miR-483−5p | downregulated | −2.20 | 2.88E-03 | 1 | 100 %; 100 % |
| hsa-miR-4732−3p | downregulated | −1.53 | 3.83E-03 | 0.98 | 94.1%; 100 % |
| hsa-miR-30a-5p | downregulated | −1.34 | 4.16E-03 | 0.98 | 94.1%; 100 % |
| hsa-miR-125b-5p | downregulated | −1.49 | 5.41E-03 | 0.94 | 82.4%; 100 % |
| hsa-miR-92a-3p | downregulated | −1.24 | 5.79E-03 | 0.98 | 94.1%; 100 % |
| hsa-miR-92b-5p | downregulated | −1.41 | 6.41E-03 | 1 | 100 %; 100 % |
| hsa-miR-1908−5p | downregulated | −1.78 | 7.62E-03 | 1 | 100 %; 100 % |
| hsa-miR-193b-5p | downregulated | −1.81 | 8.91E-03 | 0.94 | 88.2%; 100 % |
| hsa-miR-4772−3p | upregulated | 10.76 | 4.64E-06 | 1 | 100 %; 100 % |
| hsa-miR-551a | upregulated | 10.08 | 6.72E-05 | 1 | 100 %; 100 % |
| hsa-miR-425−3p | upregulated | 2.36 | 5.13E-04 | 1 | 100 %; 100 % |
| hsa-miR-1304−3p | upregulated | 2.94 | 5.31E-04 | 0.96 | 94.1%; 100 % |
| hsa-miR-345−5p | upregulated | 2.72 | 7.68E-04 | 1 | 100 %; 100 % |
| hsa-miR-223−3p | upregulated | 3.68 | 8.28E-04 | 0.92 | 88.2%; 100 % |
| hsa-miR-199b-5p | upregulated | 3.45 | 9.99E-04 | 1 | 100 %; 100 % |
| hsa-miR-30c-5p | upregulated | 1.82 | 1.54E-03 | 1 | 100 %; 100 % |
| hsa-miR-181a-3p | upregulated | 2.34 | 1.70E-03 | 0.98 | 94.1%; 100 % |
| hsa-miR-2355−5p | upregulated | 7.77 | 3.18E-03 | 0.97 | 94.1%; 100 % |
| hsa-miR-145−5p | upregulated | 3.09 | 3.22E-03 | 0.92 | 88.2%; 100 % |
| hsa-miR-26b-3p | upregulated | 2.25 | 3.32E-03 | 0.96 | 94.1%; 100 % |
| hsa-miR-425−5p | upregulated | 1.50 | 4.09E-03 | 1 | 100 %; 100 % |
| hsa-miR-146b-3p | upregulated | 2.07 | 4.13E-03 | 0.96 | 94.1%; 100 % |
| hsa-miR-454−5p | upregulated | 1.87 | 4.13E-03 | 0.94 | 94.1%; 100 % |
| hsa-miR-181a-2−3p | upregulated | 1.57 | 5.06E-03 | 1 | 100 %; 100 % |
| hsa-miR-361−3p | upregulated | 1.93 | 5.59E-03 | 0.96 | 88.2%; 100 % |
| hsa-miR-873−3p | upregulated | 7.74 | 6.09E-03 | 1 | 100 %; 100 % |
| hsa-miR-2115−5p | upregulated | 7.72 | 6.30E-03 | 0.97 | 94.1%; 100 % |
| hsa-miR-27a-3p | upregulated | 2.04 | 6.60E-03 | 1 | 100 %; 100 % |
| hsa-miR-339−5p | upregulated | 1.80 | 6.71E-03 | 0.90 | 82.4%; 100 % |
| hsa-miR-589−5p | upregulated | 2.23 | 7.08E-03 | 0.98 | 94.1%; 100 % |
| hsa-miR-23a-5p | upregulated | 3.57 | 8.15E-03 | 0.94 | 88.2%; 100 % |
| hsa-miR-941 | upregulated | 2.12 | 8.41E-03 | 0.94 | 88.2%; 100 % |
| hsa-miR-23a-3p | upregulated | 1.62 | 9.63E-03 | 0.94 | 94.1%; 100 % |
| hsa-miR-93−3p | upregulated | 1.46 | 1.02E-02 | 1 | 100 %; 100 % |
Fig. 1Expression matrix for the selected miRNA. The miRNAs are grouped as down- and upregulated in exposed with respect to control subjects.
Fig. 2Principal component analysis (PCA) performed on the miRNA of all samples of the dataset.
MANOVA test results. The Wilks test measures the statistical significance of the association between the selected miRNAs and the urinary biomarkers of dose and effect.
| miRNA | Urinary biomarker | Wilks test |
|---|---|---|
| (group of miRNA highly correlated to MHIPP) | MHIPP (μg/g Creatinine) | 0.009 ** |
| SBMA (μg/g Creatinine) | 0.04 | |
| SPMA (μg/g Creatinine) | 0.014 * | |
| Cotinine (μg/g Creatinine) | n.s | |
| (group of miRNA highly correlated to Xylenes) | Total Xylenes (ng/mL) | 0.0003 *** |
| p-xylene(ng/mL) | 0.0003 *** | |
| Toluene (ng/mL) | 0.0226 * | |
| 8-oxodGuo (μg/g Creatinine) | 0.0254 * |